SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

CTKB

Cytek Biosciences, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 14h ago SEC0001386060-26-000063
Passive stake amendment
Actionable Insight • Neutral

Monitor for any conversion to a Schedule 13D if Boston Partners engages in activist activities, but the passive certification makes this unlikely in the near term.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$5.84
T+0 close · Nov 13, 2026 · via day close
Latest settled
−3.60%
T+1 · $5.63
Vs SPY
−1.68%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $5.84entry
  2. T+1 · 19h ago −3.60%α −1.68% · $5.63
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Boston Partners filed an amended Schedule 13G disclosing a 6.16% passive stake in Cytek Biosciences as of September 30, 2026, up from a prior 5.6% stake. The increase is modest and routine for a passive institutional investor.

Key Financial Metrics

Stake
6.16%
Investor
Boston Partners
Investor Type
mutual fund

Key Facts

  • Boston Partners reported beneficial ownership of 8,002,638 shares of Cytek Biosciences common stock as of September 30, 2026.
  • The stake represents 6.16% of shares outstanding, up from 5.6% in the prior filing.
  • Boston Partners is a registered investment adviser filing under Rule 13d-1(b) as a passive investor.
  • The filing certifies the securities were acquired and are held in the ordinary course of business, not to influence control.

Financial Impact

Stake increased by approximately 0.56 percentage points; no dollar value disclosed.

Risk Factors

  • No material risks identified from this routine passive stake amendment.

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
70% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001386060-26-000063
Document: 0001386060-26-000063-index.html0001386060-26-000063
Document: 0001386060-26-000063.txt0001386060-26-000063

Track record

14 reports on CTKB

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +1.49% at T+1 after the Jun 11, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Nov 16, 20261d ago ITC Section 337 Neutral 3/10 Entry $5.78 Now $5.63 −2.60% settles Nov 18
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $5.84 to $5.63 Now $5.63 −3.60% ▼ −3.60% −1.68% vs SPY
  3. Nov 10, 20266d ago Institutional Cluster Bullish 4/10 Entry $5.79 to $5.76 Now $5.63 −2.76% ▼ −0.52% −1.84% vs SPY
  4. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  5. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $5.40 to $5.83 Now $5.63 +4.26% ▲ +7.96% +7.65% vs SPY
  6. Nov 3, 202613d ago SC 13G/A Neutral 2/10 Entry $5.88 to $5.40 Now $5.63 −4.25% ▼ −8.16% −3.75% vs SPY
  7. Oct 21, 202626d ago Press Release Neutral 1/10 Entry $5.43 to $5.59 Now $5.63 +3.68% ▲ +2.95% +3.47% vs SPY
  8. Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $5.71 to $5.68 Now $5.63 −1.40% ▼ −0.53% +0.19% vs SPY
  9. Aug 24, 202612w ago 8-K Bearish 7/10 Entry $4.44 to $4.58 Now $5.63 −26.80% ▼ −3.15% −2.83% vs SPY
  10. Jun 25, 202620w ago 8-K Neutral 2/10 Entry $4.48 to $4.34 Now $5.63 +25.67% ▼ −3.13% −4.77% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 7h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026